Cargando…
Glypican-1 in human glioblastoma: implications in tumorigenesis and chemotherapy
Glioblastoma is one of the most common malignant brain tumors, with which patients have a mean survival of 24 months. Glypican-1 has been previously shown to be overexpressed in human glioblastoma and to be negatively correlated with patient’s survival. This study aimed to investigate how glypican-1...
Autores principales: | Listik, Eduardo, Toma, Leny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061737/ https://www.ncbi.nlm.nih.gov/pubmed/32180897 http://dx.doi.org/10.18632/oncotarget.27492 |
Ejemplares similares
-
The Glypican proteoglycans show intrinsic interactions with Wnt-3a in human prostate cancer cells that are not always associated with cascade activation
por: de Moraes, Gabrielle Ferrante Alves, et al.
Publicado: (2021) -
Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
por: Kaseb, Ahmed Omar, et al.
Publicado: (2016) -
Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker
por: Levin, Rachel A., et al.
Publicado: (2018) -
Glypicans
por: Filmus, Jorge, et al.
Publicado: (2008) -
Glypican-1 as a Biomarker for Prostate Cancer: Isolation and Characterization
por: Truong, Quach, et al.
Publicado: (2016)